NEW YORK, Jan. 26, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (TGTX) today announced the commercial launch of BRIUMVI™ (ublituximab-xiiy), for the treatment of relapsing forms of multiple ...
Biogen beat Wall Street estimates for third-quarter profit, helped by better-than-expected sales of some of its multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback